Tag Archives: NIST

IOM: Curb Fake Meds through Track-and-Trace, but Forget "Counterfeits"

A new report from the Institute of Medicine (IOM) has drawn a lot of attention to the public health dangers of falsified and substandard medicines around the world. The aim is to build support for a range of activities that can limit the spread of fake medicines in the U.S. and help developing nations strengthen […]
Posted in Anti-counterfeiting, compliance, Events, FDA, Manufacturing, R&D, Regulatory, Safety, Strategy, Supply Chain | Also tagged , , , , | Leave a comment
  • Categories

  • Meta